REPORT ID 5183

EMEA (Europe, Middle East and Africa) Veterinary Drugs Market Report 2017

Publish Date
20-Dec-17
Pages
102
Format
Electronic (PDF)

In this report, the EMEA Veterinary Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Veterinary Drugs for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Veterinary Drugs market competition by top manufacturers/players, with Veterinary Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Zoetis
    Boehringer Ingelheim
    Bayer
    Elanco Animal Health
    Ceva
    Dechra
    Merck
    Virbac
    Vetoquinol

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Anti-infective
    Anti-inflammatory
    Parasiticides

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Veterinary Drugs for each application, including
    Livestock
    Companion

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Veterinary Drugs Market Report 2017
1 Veterinary Drugs Overview
    1.1 Product Overview and Scope of Veterinary Drugs
    1.2 Classification of Veterinary Drugs
        1.2.1 EMEA Veterinary Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Veterinary Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Anti-infective
        1.2.4 Anti-inflammatory
        1.2.5 Parasiticides
    1.3 EMEA Veterinary Drugs Market by Application/End Users
        1.3.1 EMEA Veterinary Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Livestock
        1.3.3 Companion
    1.4 EMEA Veterinary Drugs Market by Region
        1.4.1 EMEA Veterinary Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Veterinary Drugs (2012-2022)
        1.5.1 EMEA Veterinary Drugs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Veterinary Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Veterinary Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Veterinary Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Veterinary Drugs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Veterinary Drugs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Veterinary Drugs Sale Price by Players (2012-2017)
    2.2 EMEA Veterinary Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Veterinary Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Veterinary Drugs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Veterinary Drugs Sale Price by Type (2012-2017)
    2.3 EMEA Veterinary Drugs (Volume) by Application
    2.4 EMEA Veterinary Drugs (Volume and Value) by Region
        2.4.1 EMEA Veterinary Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Veterinary Drugs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Veterinary Drugs Sales Price by Region (2012-2017)

3 Europe Veterinary Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Veterinary Drugs Sales and Value (2012-2017)
        3.1.1 Europe Veterinary Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Veterinary Drugs Revenue and Growth Rate (2012-2017)
    3.2 Europe Veterinary Drugs Sales and Market Share by Type
    3.3 Europe Veterinary Drugs Sales and Market Share by Application
    3.4 Europe Veterinary Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Veterinary Drugs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Veterinary Drugs Revenue by Countries (2012-2017)
        3.4.3 Germany Veterinary Drugs Sales and Growth Rate (2012-2017)
        3.4.4 France Veterinary Drugs Sales and Growth Rate (2012-2017)
        3.4.5 UK Veterinary Drugs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Veterinary Drugs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Veterinary Drugs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Veterinary Drugs Sales and Growth Rate (2012-2017)

4 Middle East Veterinary Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Veterinary Drugs Sales and Value (2012-2017)
        4.1.1 Middle East Veterinary Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Veterinary Drugs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Veterinary Drugs Sales and Market Share by Type
    4.3 Middle East Veterinary Drugs Sales and Market Share by Application
    4.4 Middle East Veterinary Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Veterinary Drugs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Veterinary Drugs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Veterinary Drugs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Veterinary Drugs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Veterinary Drugs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Veterinary Drugs Sales and Growth Rate (2012-2017)

5 Africa Veterinary Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Veterinary Drugs Sales and Value (2012-2017)
        5.1.1 Africa Veterinary Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Veterinary Drugs Revenue and Growth Rate (2012-2017)
    5.2 Africa Veterinary Drugs Sales and Market Share by Type
    5.3 Africa Veterinary Drugs Sales and Market Share by Application
    5.4 Africa Veterinary Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Veterinary Drugs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Veterinary Drugs Revenue by Countries (2012-2017)
        5.4.3 South Africa Veterinary Drugs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Veterinary Drugs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Veterinary Drugs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Veterinary Drugs Sales and Growth Rate (2012-2017)

6 EMEA Veterinary Drugs Manufacturers/Players Profiles and Sales Data
    6.1 Zoetis
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Veterinary Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Zoetis Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boehringer Ingelheim
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Veterinary Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boehringer Ingelheim Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Bayer
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Veterinary Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Bayer Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Elanco Animal Health
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Veterinary Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Elanco Animal Health Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Ceva
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Veterinary Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Ceva Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Dechra
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Veterinary Drugs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Dechra Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Merck
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Veterinary Drugs Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Merck Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Virbac
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Veterinary Drugs Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Virbac Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Vetoquinol
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Veterinary Drugs Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Vetoquinol Veterinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Veterinary Drugs Manufacturing Cost Analysis
    7.1 Veterinary Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Veterinary Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Veterinary Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Veterinary Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Veterinary Drugs Market Forecast (2017-2022)
    11.1 EMEA Veterinary Drugs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Veterinary Drugs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Veterinary Drugs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Veterinary Drugs Price and Trend Forecast (2017-2022)
    11.2 EMEA Veterinary Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Veterinary Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Veterinary Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Veterinary Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Veterinary Drugs Sales Forecast by Type (2017-2022)
    11.7 EMEA Veterinary Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer